Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 7/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.60 |
| ▸ | MAPT | P10636 | 6/20 | 0.60 |
| ▸ | MEN1 | O00255 | 6/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.60 |
| ▸ | GAA | P10253 | 3/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 6/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | DPP4 | P27487 | 2/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13233272 | 0.89 | KMT2A (0.64) | RAB9AKMT2AMAPTMEN1SMN1; SMN2 | |
| SCHEMBL7026260 | 0.89 | DPP4 (0.56) | RAB9AKMT2AMAPTMEN1SMN1; SMN2 | |
| SCHEMBL2790531 | 0.82 | SMN1; SMN2 (0.58) | RAB9AKMT2AMAPTMEN1SMN1; SMN2 | |
| SCHEMBL5151678 | 0.80 | GAA (0.64) | RAB9AKMT2AMAPTMEN1SMN1; SMN2 | |
| SCHEMBL9143702 | 0.80 | SMN1; SMN2 (0.63) | RAB9AKMT2AMAPTMEN1SMN1; SMN2 | |
| SCHEMBL13602607 | 0.79 | KMT2A (0.60) | RAB9AKMT2AMAPTMEN1SMN1; SMN2 | |
| SCHEMBL7751102 | 0.78 | MAPT (0.59) | RAB9AKMT2AMAPTMEN1SMN1; SMN2 | |
| SCHEMBL1146057 | 0.77 | SMN1; SMN2 (0.60) | RAB9AKMT2AMAPTMEN1SMN1; SMN2 | |
| SCHEMBL30014816 | 0.77 | SMN1; SMN2 (0.60) | RAB9AKMT2AMAPTMEN1SMN1; SMN2 | |
| SCHEMBL5650522 | 0.77 | SMN1; SMN2 (0.60) | RAB9AKMT2AMAPTMEN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040180925-A1 | Dipeptidylpeptidase-IV inhibitor | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2004-09-16 | — | — | US | disclosed |
| EP-1354882-A1 | DIPEPTIDYL PEPTIDASE IV INHIBITOR | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2003-10-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040180925-A1 | Dipeptidylpeptidase-IV inhibitor | DPP4, DPP3, DPP9 | RAB9A 2032/4885KMT2A 4164/4885MAPT 3376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.